Lerochol is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for ...

The global smart syringes market is set for robust growth, with an estimated size of USD 1.05 billion in 2024 and a projection to reach USD 2.22 billion by 2033. This represents a ...

Fresenius Kabi has introduced two new products in its Simplist portfolio of ready-to-administer prefilled syringes: Simplist ...

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced two new products in its ...

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...

The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...

The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable ...

To ensure Humira maintains its potency and effectiveness when you’re ready to inject it, you will need to keep it ...

The US drug regulator has approved the Armlupeg (pegfilgrastim-unne) 6mg / 0.6 ml injection for subcutaneous use in a single-dose pre-filled syringe, as the biosimilar to Neulasta (pegfilgrastim) 6mg ...

Many residents have expressed concerns with needle litter throughout the city. Public health experts say stopping the program ...